| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |